The study found that VDR expression was reduced in both diabetic nephropathy mouse models and renal ischemia-reperfusion rat models, and the administration of VDR activators could alleviate renal ischemia-reperfusion injury in rats [14,15]. Here, VDR is linked to diabetic kidney disease.